A 4-week study of a mouse multiple sclerosis (MS) model capturing the pathophysiology of autoimmunity and neuroinflammation ASGCT 2025 – Multiple sclerosis (MS) is a debilitating, chronic, neurological autoimmune disorder affecting 1 in 3,000 people caused by the loss of myelin, and manifests in symptoms ranging from mild to severe paralysis. MS can significantly impact mobility and coordination, leading to difficulties with walking, standing and balance. The primary event leading to symptomatic pathology is the infiltration of peripheral immune cells that have been primed against…